As expected, patients with PRR11- negative tumor had a more favorable time to recurrence than those with any level of PRR11 positive tumor (p = 0.002, vs. PRR11+ tumor; p < 0.001, vs. PRR11 ++ and +++ tumor, Figure 3B). Here, PRR11 is linked to neoplasm.